Transoral robotic surgery (TORS) has become increasingly accepted as a treatment modality in human papillomavirus (HPV)-positive T1/T2 oropharyngeal squamous cell carcinoma (OPSCC).
Transoral robotic surgery (TORS) has become increasingly accepted as a treatment modality in human papillomavirus (HPV)-positive T1/T2 oropharyngeal squamous cell carcinoma (OPSCC).